When standard mammograms are not enough: who may need advanced breast imaging

Mammography is still the main breast cancer screening test, but on Oct. 27, 2026, UrbanMatter explained that it does not work equally well for everyone. The article says women with dense breast tissue, people at higher genetic risk, and patients who need a more detailed look at a suspicious finding may need advanced breast imaging in addition to standard screening.

Why mammography can fall short

According to UrbanMatter, standard mammograms use low-dose X-rays and are most effective when the breast tissue is fatty. In that setting, tumors stand out more clearly. The problem is that dense breast tissue also appears white on a mammogram, which can make a cancer harder to see because it blends in with the surrounding tissue.

The article describes this as a “hiding in plain sight” issue. It says mammography sensitivity can drop from about 85% to 90% in fatty breasts to 60% to 70% in extremely dense breasts. It also notes that about half of women ages 40 to 74 have dense breast tissue, making this a common limitation rather than a rare one.

UrbanMatter adds that mammography can be less useful for some tumor types, especially lobular carcinoma, and that it may not show the full extent of disease once cancer is found. That matters because doctors use imaging not only to detect cancer, but also to plan surgery and other treatment.

Who may need more than standard screening

The article says supplemental imaging is most relevant for three groups: women with dense breasts, people at elevated genetic risk, and patients who need further evaluation after an abnormal mammogram. It says the decision should be based on personal risk rather than a one-size-fits-all approach.

• Women with dense breasts: Mammography may miss cancers hidden by overlapping tissue.
• People at higher genetic risk: The article points to BRCA1 and BRCA2 carriers and others with strong hereditary risk.
• Patients with suspicious findings: Extra imaging can help determine whether a finding needs biopsy or closer follow-up.
• People already diagnosed with breast cancer: More detailed imaging can help define how far the disease has spread.

UrbanMatter says women with dense breasts should talk with a healthcare provider about whether added screening makes sense, especially if other risk factors are present. It also notes that people with certain genetic syndromes, a strong family history, or prior chest radiation at a young age may need closer surveillance.

Advanced imaging tools and what they add

The article highlights ultrasound, 3D mammography, and MRI as the most important supplemental tools. Ultrasound uses sound waves rather than radiation and is often used to sort out cysts from solid masses. UrbanMatter says it can find additional cancers in dense breasts, but it also leads to more false alarms and more benign biopsies.

Tomosynthesis, also called 3D mammography, takes images from several angles and builds a layered view of the breast. According to the article, this reduces the problem of overlapping tissue and improves cancer detection compared with standard mammography, though it still has limits in very dense breasts.

MRI is described as the most sensitive breast imaging test. UrbanMatter says it is especially important for women at high genetic risk and for some patients with a lifetime breast cancer risk above 20%. In those groups, MRI is often used with mammography because it can find cancers that other tests miss.

Why this matters for everyday screening

For average-risk women with non-dense breasts, the article says mammography remains the right starting point. Adding more imaging in low-risk groups can increase false positives, costs, and unnecessary procedures without providing enough extra benefit. UrbanMatter says the challenge is matching the test to the person.

That is where understanding breast density and personal risk becomes important. The article says insurance coverage also varies, and MRI screening is more likely to be covered for high-risk patients than for density alone. For ordinary readers, the practical message is that a screening plan may need to change if breast density, family history, genetic testing, or a new abnormal finding changes the level of risk.

UrbanMatter’s broader point is that breast imaging has moved beyond a single approach for everyone. Standard mammography remains essential, but for some patients it is only part of the picture.

Source: UrbanMatter Staff